Boundless Bio, Inc.
BOLD
$1.58
$0.0755.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.00M | 16.42M | 15.10M | 13.33M | 12.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.27M | 68.79M | 65.02M | 59.59M | 54.80M |
| Operating Income | -73.27M | -68.79M | -65.02M | -59.59M | -54.80M |
| Income Before Tax | -65.36M | -61.06M | -57.72M | -53.15M | -49.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -65.36 | -61.06 | -57.72 | -53.15 | -49.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.36M | -61.06M | -57.72M | -53.15M | -49.43M |
| EBIT | -73.27M | -68.79M | -65.02M | -59.59M | -54.80M |
| EBITDA | -72.18M | -67.75M | -64.01M | -58.61M | -53.84M |
| EPS Basic | -14.52 | -23.55 | -33.52 | -43.03 | -40.67 |
| Normalized Basic EPS | -9.07 | -14.72 | -20.95 | -26.89 | -25.42 |
| EPS Diluted | -14.52 | -23.55 | -33.52 | -43.03 | -40.67 |
| Normalized Diluted EPS | -9.07 | -14.72 | -20.95 | -26.89 | -25.42 |
| Average Basic Shares Outstanding | 67.82M | 46.78M | 25.75M | 4.94M | 4.86M |
| Average Diluted Shares Outstanding | 67.82M | 46.78M | 25.75M | 4.94M | 4.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |